3 completed. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 3 |
Follow GATT Technologies BV: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery GATT-Patch, SURGICEL® Original - Intraoperative Bleeding, Liver Diseases | Not applicable | Completed | GATT Technologies BV | 53 | 2023-10-02 | 2026-02-12 |
| GATT-Patch Versus TachoSil in Liver Surgery GATT-Patch (currently named ETHIZIA), TachoSil - Intraoperative Bleeding, Hemorrhage, Surgical | Not applicable | Completed | GATT Technologies BV | 132 | 2022-08-04 | 2026-03-04 |
| Clinical Safety and Performance of GATT-Patch in Open Liver Surgery GATT-Patch - Hemorrhage, Surgical | Not applicable | Completed | GATT Technologies BV | 56 | 2021-04-16 | 2024-09-19 |
Blood Loss, Surgical (3) · Liver Diseases (2) · Gallbladder Diseases (1)
TachoSil (1)
Netherlands (2) · United States (2) · Germany (1)
Hans de Wilt (1) · Hans de Wilt, Prof. dr. (1) · Harry van Goor, Prof. dr. (1) · James Guarrera (1)